Oncoinvent AS

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with Oncoinvent AS’ NOK 71 million private placement.

The net proceeds from the private placement are expected to ensure financing until the end of Q1 2025.

Carnegie would like to congratulate Oncoinvent on the completed private placement and is grateful for the vote of confidence.

Related articles

Schibsted
Investment Banking

Schibsted

Acquisition of 9.99% in FINN – NOK 2.5 billion Carnegie Investment Bank acted as financial advisor to...

BerGenBio ASA
Investment Banking

BerGenBio ASA

Carnegie Investment Bank is proud to have acted as manager in the exercise of warrants in...

SpinChip Diagnostics ASA
Investment Banking

SpinChip Diagnostics ASA

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with SpinChip Diagnostics ASA’...